CTNM
Contineum Therapeutics, Inc. Class A Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:53 PM EDT
13.12USD+1.039%(+0.13)794,261
Loading…
Loading…
495.47M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Previous Close
$12.99
Beta
1.25
52-Week High
$17.79 2026-09-03
52-Week Low
$8.60 2026-01-08
SMA 50
$14.89
SMA 200
$13.71
Avg. Vol 10D
755,258
Avg. Vol 30D
587,343
Avg. Vol 90D
471,682
Relative Vol
1.35
37.62M
27.76M
73.79%
2,443,708
8.80%
6.94
54%/46%
65.04%
57.02%
0.4900%
650,000
40
Oct 29, 2026 (24d)
Sep 30, 2026
Stifel reiterates Contineum Therapeutics stock rating at buy · 
Investing.com
Sep 24, 2026
Goldman Sachs initiates coverage on Contineum Therapeutics stock · Investing.com
CTNM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 12.73 | 2026-09-28 | +3.46% | -3.623 |
| 1M | 16.70 | 2026-09-04 | -21.14% | 1.127 |
| 3M | 15.53 | 2026-07-06 | -15.20% | 1.629 |
| 6M | 13.44 | 2026-04-06 | -2.01% | 1.728 |
| 1Y | 11.08 | 2025-10-06 | +18.86% | 1.254 |
| 2Y | 17.00 | 2024-10-04 | -22.53% | — |
CTNM Stock Summary
Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ:CTNM) stock price today is $13.17, and today's volume is 794,261. CTNM is up 1.386% today. The 30 day average volume is 587,343. CTNM market cap is $495.47M with 37.62M shares outstanding.